Explore more publications!
Healthy Living South Dakota
Got News to Share?

Healthy Living South Dakota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living South Dakota.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on September 24, 2025

MAIA Biotechnology Awarded $2.3 Million Grant by National Institutes of Health for THIO-101 Phase 2 Trial of Cancer-Fighting Agent
September 24, 2025

MAIA Biotechnology Awarded $2.3 Million Grant by National Institutes of Health for THIO-101 Phase 2 Trial of Cancer-Fighting Agent

Indeterminate GlobeNewswire
Aging in Place, Limited Access to Medical Care and Economic Insecurity Threaten U.S. Senior Health
September 24, 2025

Aging in Place, Limited Access to Medical Care and Economic Insecurity Threaten U.S. Senior Health

Indeterminate GlobeNewswire
Daré Bioscience to Receive up to $499,000 to Support Preeclampsia Research
September 24, 2025

Daré Bioscience to Receive up to $499,000 to Support Preeclampsia Research

Indeterminate GlobeNewswire
NewAmsterdam Pharma to Present at the Stifel 2025 Virtual Cardiometabolic Forum
September 24, 2025

NewAmsterdam Pharma to Present at the Stifel 2025 Virtual Cardiometabolic Forum

Indeterminate GlobeNewswire
Kura Oncology to Participate in Upcoming Investor Conference
September 24, 2025

Kura Oncology to Participate in Upcoming Investor Conference

Indeterminate GlobeNewswire
LEQEMBI® (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Australia
September 24, 2025

LEQEMBI® (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Australia

Indeterminate GlobeNewswire
Cytokinetics Announces Call for Proposals for Its Eighth Annual Communications Grant Program
September 24, 2025

Cytokinetics Announces Call for Proposals for Its Eighth Annual Communications Grant Program

Indeterminate GlobeNewswire
uniQure Announces Refinancing of Existing $50 Million Debt and Securing Up to an Additional $125 Million in Non-Dilutive Funding
September 24, 2025

uniQure Announces Refinancing of Existing $50 Million Debt and Securing Up to an Additional $125 Million in Non-Dilutive Funding

Indeterminate GlobeNewswire
Healthcare as the World’s Most Strategic Investment: KFSHRC CEO Calls for Global Collaboration at C3 Japan Summit
September 24, 2025

Healthcare as the World’s Most Strategic Investment: KFSHRC CEO Calls for Global Collaboration at C3 Japan Summit

Indeterminate GlobeNewswire
Insight Molecular Diagnostics to Showcase Leadership in Kidney Transplant Management at Conferences in Singapore and Orlando
September 24, 2025

Insight Molecular Diagnostics to Showcase Leadership in Kidney Transplant Management at Conferences in Singapore and Orlando

Indeterminate GlobeNewswire
uniQure Announces Positive Topline Results from Pivotal Phase I/II Study of AMT-130 in Patients with Huntington’s Disease
September 24, 2025

uniQure Announces Positive Topline Results from Pivotal Phase I/II Study of AMT-130 in Patients with Huntington’s Disease

Indeterminate GlobeNewswire
BIO-Europe® 2025: Vienna Prepares to Welcome Global Biopharma Leaders
September 24, 2025

BIO-Europe® 2025: Vienna Prepares to Welcome Global Biopharma Leaders

Indeterminate GlobeNewswire
LUKE Calls for National Partnerships to Help America’s Heroes Flourish
September 24, 2025

LUKE Calls for National Partnerships to Help America’s Heroes Flourish

Indeterminate GlobeNewswire
Sagimet Biosciences Announces Upcoming Panel Participation at Fierce Biotech Week
September 24, 2025

Sagimet Biosciences Announces Upcoming Panel Participation at Fierce Biotech Week

Indeterminate GlobeNewswire
FibroGen Initiates Phase 2 Monotherapy Trial of FG-3246, a First-in-Class CD46 Targeting ADC, in Metastatic Castration-Resistant Prostate Cancer
September 24, 2025

FibroGen Initiates Phase 2 Monotherapy Trial of FG-3246, a First-in-Class CD46 Targeting ADC, in Metastatic Castration-Resistant Prostate Cancer

Indeterminate GlobeNewswire
Cidara Therapeutics Announces Expanded and Accelerated Phase 3 Plan for CD388, a Non-Vaccine Preventative of Seasonal Influenza
September 24, 2025

Cidara Therapeutics Announces Expanded and Accelerated Phase 3 Plan for CD388, a Non-Vaccine Preventative of Seasonal Influenza

Indeterminate GlobeNewswire
Medical Teams International President & CEO Advocates for Increased Mental Health Support for Children in Sudan
September 24, 2025

Medical Teams International President & CEO Advocates for Increased Mental Health Support for Children in Sudan

Indeterminate GlobeNewswire
ITM and TerThera Sign Supply Agreement for Medical Radioisotope Terbium-161
September 24, 2025

ITM and TerThera Sign Supply Agreement for Medical Radioisotope Terbium-161

Indeterminate GlobeNewswire
CARBIOS berichtet Finanzergebnisse für das erste Halbjahr 2025 und bestätigt seinen Plan, eine PET-Biorecyclinganlage zu bauen, mit überarbeitetem Zeitplan
September 24, 2025

CARBIOS berichtet Finanzergebnisse für das erste Halbjahr 2025 und bestätigt seinen Plan, eine PET-Biorecyclinganlage zu bauen, mit überarbeitetem Zeitplan

Indeterminate GlobeNewswire
Burning Rock's OncoGuide™ OncoScreen™ Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer
September 24, 2025

Burning Rock's OncoGuide™ OncoScreen™ Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions